Amgen Inc. Proceeds from Long-Term Debt Issued
Amgen Inc. (AMGN) reported Proceeds from Long-Term Debt Issued of $3.96 billion for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfLongTermDebt · last filed 2026-08-05
- Amgen Inc. proceeds from issuance of long-term debt for the quarter ending 2026-06-30 was $0.00.
- Amgen Inc. proceeds from issuance of long-term debt for the quarter ending 2026-03-31 was $3.96B.
- Amgen Inc. proceeds from issuance of long-term debt for the quarter ending 2025-06-30 was $0.00.
- Amgen Inc. proceeds from issuance of long-term debt for the quarter ending 2025-03-31 was $0.00.
- Amgen Inc. proceeds from issuance of long-term debt for fiscal 2025 was $0.00.
- Amgen Inc. proceeds from issuance of long-term debt for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- Amgen Inc. proceeds from issuance of long-term debt for fiscal 2023 was $27.78B, a 301.46% increase from fiscal 2022.
- Amgen Inc. proceeds from issuance of long-term debt for fiscal 2022 was $6.92B, a 39.92% increase from fiscal 2021.
| Period end | Proceeds from Issuance of Long-term Debt 3 month | Proceeds from Issuance of Long-term Debt 6 month | Proceeds from Issuance of Long-term Debt 9 month | Proceeds from Issuance of Long-term Debt 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $3.96B 10-Q · filed 2026-08-05 | ||
| 2026-03-31 | $3.96B 10-Q · filed 2026-05-01 | |||
| 2025-12-31 | $0.00 10-K · filed 2026-02-13 | |||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $0.00 10-Q · filed 2026-08-05 | $0.00 derived: sum of 3 quarters · filed 2026-08-05 | $0.00 derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-01 | $0.00 derived: sum of 2 quarters · filed 2026-05-01 | $0.00 derived: sum of 3 quarters · filed 2026-05-01 | $0.00 derived: sum of 4 quarters · filed 2026-05-01 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $0.00 derived: sum of 2 quarters · filed 2026-02-13 | $0.00 derived: sum of 3 quarters · filed 2026-02-13 | $0.00 10-K · filed 2026-02-13 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $0.00 derived: sum of 2 quarters · filed 2024-10-31 | $0.00 10-Q · filed 2024-10-31 | $4.00B derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $0.00 10-Q · filed 2024-08-07 | $4.00B derived: sum of 3 quarters · filed 2026-02-13 | $4.00B derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-03 | $4.00B derived: sum of 2 quarters · filed 2026-02-13 | $4.00B derived: sum of 3 quarters · filed 2026-02-13 | $3.98B derived: sum of 4 quarters · filed 2026-02-13 |
| 2023-12-31 | $4.00B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $4.00B derived: sum of 2 quarters · filed 2026-02-13 | $3.98B derived: sum of 3 quarters · filed 2026-02-13 | $27.78B 10-K · filed 2026-02-13 |
| 2023-09-30 | $1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | -$17.00M derived: sum of 2 quarters · filed 2024-10-31 | $23.78B 10-Q · filed 2024-10-31 | $23.76B derived: sum of 4 quarters · filed 2025-02-14 |
| 2023-06-30 | -$18.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $23.78B 10-Q · filed 2024-08-07 | $23.76B derived: sum of 3 quarters · filed 2025-02-14 | $26.75B derived: sum of 4 quarters · filed 2025-02-14 |
| 2023-03-31 | $23.80B 10-Q · filed 2024-05-03 | $23.78B derived: sum of 2 quarters · filed 2025-02-14 | $26.76B derived: sum of 3 quarters · filed 2025-02-14 | $26.77B derived: sum of 4 quarters · filed 2025-02-14 |
| 2022-12-31 | -$19.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | $2.96B derived: sum of 2 quarters · filed 2025-02-14 | $2.97B derived: sum of 3 quarters · filed 2025-02-14 | $6.92B 10-K · filed 2025-02-14 |
| 2022-09-30 | $2.98B derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-31 | $2.99B derived: sum of 2 quarters · filed 2023-10-31 | $6.94B 10-Q · filed 2023-10-31 | $6.94B derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-06-30 | $2.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $3.95B 10-Q · filed 2023-08-04 | $3.95B derived: sum of 3 quarters · filed 2024-02-14 | $8.90B derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-03-31 | $3.95B 10-Q · filed 2023-04-28 | $3.95B derived: sum of 2 quarters · filed 2024-02-14 | $8.90B derived: sum of 3 quarters · filed 2024-02-14 | $8.90B derived: sum of 4 quarters · filed 2024-02-14 |
| 2021-12-31 | -$1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $4.95B derived: sum of 2 quarters · filed 2024-02-14 | $4.95B derived: sum of 3 quarters · filed 2024-02-14 | $4.95B 10-K · filed 2024-02-14 |
| 2021-09-30 | $4.95B derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $4.95B derived: sum of 2 quarters · filed 2022-11-04 | $4.95B 10-Q · filed 2022-11-04 | $4.95B derived: sum of 4 quarters · filed 2023-02-09 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $0.00 10-Q · filed 2022-08-05 | $0.00 derived: sum of 3 quarters · filed 2023-02-09 | -$88.00M derived: sum of 4 quarters · filed 2023-02-09 |
| 2021-03-31 | $0.00 10-Q · filed 2022-04-28 | $0.00 derived: sum of 2 quarters · filed 2023-02-09 | -$88.00M derived: sum of 3 quarters · filed 2023-02-09 | $3.95B derived: sum of 4 quarters · filed 2023-02-09 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-09 | -$88.00M derived: sum of 2 quarters · filed 2023-02-09 | $3.95B derived: sum of 3 quarters · filed 2023-02-09 | $8.91B 10-K · filed 2023-02-09 |
| 2020-09-30 | -$88.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $3.95B derived: sum of 2 quarters · filed 2021-11-03 | $8.91B 10-Q · filed 2021-11-03 | $8.91B derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-06-30 | $4.04B derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $9.00B 10-Q · filed 2021-08-04 | $9.00B derived: sum of 3 quarters · filed 2022-02-16 | $9.00B derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-03-31 | $4.96B 10-Q · filed 2021-04-28 | $4.96B derived: sum of 2 quarters · filed 2022-02-16 | $4.96B derived: sum of 3 quarters · filed 2022-02-16 | $4.96B derived: sum of 4 quarters · filed 2022-02-16 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | $0.00 derived: sum of 2 quarters · filed 2022-02-16 | $0.00 derived: sum of 3 quarters · filed 2022-02-16 | $0.00 10-K · filed 2022-02-16 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $0.00 derived: sum of 2 quarters · filed 2020-10-29 | $0.00 10-Q · filed 2020-10-29 | $0.00 derived: sum of 4 quarters · filed 2021-02-09 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-29 | $0.00 10-Q · filed 2020-07-29 | $0.00 derived: sum of 3 quarters · filed 2021-02-09 | $0.00 derived: sum of 4 quarters · filed 2021-02-09 |
| 2019-03-31 | $0.00 10-Q · filed 2020-05-01 | $0.00 derived: sum of 2 quarters · filed 2021-02-09 | $0.00 derived: sum of 3 quarters · filed 2021-02-09 | |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-09 | $0.00 derived: sum of 2 quarters · filed 2021-02-09 | $0.00 10-K · filed 2021-02-09 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-31 | $0.00 10-Q · filed 2018-10-31 | ||
| 2018-06-30 | $0.00 10-Q · filed 2018-07-27 | |||
| 2017-12-31 | $991.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-12 | $991.00M derived: sum of 2 quarters · filed 2020-02-12 | $4.48B derived: sum of 3 quarters · filed 2020-02-12 | $4.48B 10-K · filed 2020-02-12 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-31 | $3.48B derived: sum of 2 quarters · filed 2018-10-31 | $3.48B 10-Q · filed 2018-10-31 | $4.09B derived: sum of 4 quarters · filed 2019-02-13 |
| 2017-06-30 | $3.48B derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-27 | $3.48B 10-Q · filed 2018-07-27 | $4.09B derived: sum of 3 quarters · filed 2019-02-13 | $7.89B derived: sum of 4 quarters · filed 2019-02-13 |
| 2017-03-31 | $0.00 10-Q · filed 2017-04-27 | $605.00M derived: sum of 2 quarters · filed 2019-02-13 | $4.41B derived: sum of 3 quarters · filed 2019-02-13 | $4.41B derived: sum of 4 quarters · filed 2019-02-13 |
| 2016-12-31 | $605.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-13 | $4.41B derived: sum of 2 quarters · filed 2019-02-13 | $4.41B derived: sum of 3 quarters · filed 2019-02-13 | $7.32B 10-K · filed 2019-02-13 |
| 2016-09-30 | $3.81B derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-26 | $3.80B derived: sum of 2 quarters · filed 2017-10-26 | $6.71B 10-Q · filed 2017-10-26 | $6.71B derived: sum of 4 quarters · filed 2018-02-13 |
| 2016-06-30 | -$1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-26 | $2.91B 10-Q · filed 2017-07-26 | $2.91B derived: sum of 3 quarters · filed 2018-02-13 | $2.91B derived: sum of 4 quarters · filed 2018-02-13 |
| 2016-03-31 | $2.91B 10-Q · filed 2017-04-27 | $2.91B derived: sum of 2 quarters · filed 2018-02-13 | $2.91B derived: sum of 3 quarters · filed 2018-02-13 | $6.37B derived: sum of 4 quarters · filed 2018-02-13 |
| 2015-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | $1.00M derived: sum of 2 quarters · filed 2018-02-13 | $3.46B derived: sum of 3 quarters · filed 2018-02-13 | $3.46B 10-K · filed 2018-02-13 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-28 | $3.46B derived: sum of 2 quarters · filed 2016-10-28 | $3.46B 10-Q · filed 2016-10-28 | $3.46B derived: sum of 4 quarters · filed 2017-02-14 |
| 2015-06-30 | $3.46B derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-29 | $3.46B 10-Q · filed 2016-07-29 | $3.46B derived: sum of 3 quarters · filed 2017-02-14 | $3.46B derived: sum of 4 quarters · filed 2017-02-14 |
| 2015-03-31 | $0.00 10-Q · filed 2016-05-02 | $0.00 derived: sum of 2 quarters · filed 2017-02-14 | $0.00 derived: sum of 3 quarters · filed 2017-02-14 | |
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | $0.00 derived: sum of 2 quarters · filed 2017-02-14 | $4.48B 10-K · filed 2017-02-14 | |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-02 | $4.48B 10-Q · filed 2015-11-02 | ||
| 2014-06-30 | $4.48B 10-Q · filed 2015-08-05 | |||
| 2013-12-31 | $4.98B derived: 8-K 12 month − 10-Q 9 month · filed 2016-10-31 | $8.05B derived: sum of 2 quarters · filed 2016-10-31 | $8.05B 8-K · filed 2016-10-31 | |
| 2013-09-30 | $3.07B derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-29 | $3.07B 10-Q · filed 2014-10-29 | ||
| 2013-06-30 | $0.00 10-Q · filed 2014-08-05 | |||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-19 | $1.95B derived: sum of 2 quarters · filed 2015-02-19 | $4.93B 10-K · filed 2015-02-19 | |
| 2012-09-30 | $1.95B derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-29 | $4.93B 10-Q · filed 2013-10-29 | ||
| 2012-06-30 | $2.98B 10-Q · filed 2013-08-06 | |||
| 2011-12-31 | $7.41B derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-24 | $7.41B derived: sum of 2 quarters · filed 2014-02-24 | $10.39B derived: sum of 3 quarters · filed 2014-02-24 | $10.39B 10-K · filed 2014-02-24 |
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $2.97B derived: sum of 2 quarters · filed 2012-11-06 | $2.97B 10-Q · filed 2012-11-06 | $2.97B derived: sum of 4 quarters · filed 2013-02-27 |
| 2011-06-30 | $2.97B derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08 | $2.97B 10-Q · filed 2012-08-08 | $2.97B derived: sum of 3 quarters · filed 2013-02-27 | $4.46B derived: sum of 4 quarters · filed 2013-02-27 |
| 2011-03-31 | $0.00 10-Q · filed 2011-05-10 | $0.00 derived: sum of 2 quarters · filed 2013-02-27 | $1.48B derived: sum of 3 quarters · filed 2013-02-27 | $1.48B derived: sum of 4 quarters · filed 2013-02-27 |
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $1.48B derived: sum of 2 quarters · filed 2013-02-27 | $1.48B derived: sum of 3 quarters · filed 2013-02-27 | $2.47B 10-K · filed 2013-02-27 |
| 2010-09-30 | $1.48B derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | $1.48B derived: sum of 2 quarters · filed 2011-11-04 | $2.47B 10-Q · filed 2011-11-04 | $2.47B derived: sum of 4 quarters · filed 2012-02-29 |
| 2010-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-08 | $989.00M 10-Q · filed 2011-08-08 | $989.00M derived: sum of 3 quarters · filed 2012-02-29 | $989.00M derived: sum of 4 quarters · filed 2012-02-29 |
| 2010-03-31 | $989.00M 10-Q · filed 2011-05-10 | $989.00M derived: sum of 2 quarters · filed 2012-02-29 | $989.00M derived: sum of 3 quarters · filed 2012-02-29 | $989.00M derived: sum of 4 quarters · filed 2012-02-29 |
| 2009-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-29 | $0.00 derived: sum of 2 quarters · filed 2012-02-29 | $0.00 derived: sum of 3 quarters · filed 2012-02-29 | $1.98B 10-K · filed 2012-02-29 |
| 2009-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-08 | $0.00 derived: sum of 2 quarters · filed 2010-11-08 | $1.98B 10-Q · filed 2010-11-08 | $1.98B derived: sum of 4 quarters · filed 2011-02-25 |
| 2009-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2010-08-09 | $1.98B 10-Q · filed 2010-08-09 | $1.98B derived: sum of 3 quarters · filed 2011-02-25 | $1.98B derived: sum of 4 quarters · filed 2011-02-25 |
| 2009-03-31 | $1.98B 10-Q · filed 2010-05-07 | $1.98B derived: sum of 2 quarters · filed 2011-02-25 | $1.98B derived: sum of 3 quarters · filed 2011-02-25 | |
| 2008-12-31 | -$1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-25 | -$1.00M derived: sum of 2 quarters · filed 2011-02-25 | $991.00M 10-K · filed 2011-02-25 | |
| 2008-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2009-11-06 | $992.00M 10-Q · filed 2009-11-06 | ||
| 2008-06-30 | $992.00M 10-Q · filed 2009-08-10 | |||
| 2007-12-31 | $3.98B 10-K · filed 2010-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GILEAD SCIENCES, INC. (GILD) | United States | $185.522B | -48.37 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |